Shenyang Xingqi Pharmaceutical Hits Day Low Amid Price Pressure at CNY 35.13

Shenyang Xingqi Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 3.46% on June 8, 2026. The stock reached an intraday low of CNY 35.13, reflecting a challenging trading session. Over the past week, the stock has seen a decrease of 8.09%, and its performance over the last month has been significantly impacted, with a decline of 26.39%. In comparison, the China Shanghai Composite index has also faced downward pressure, declining by 1.7% today and 2.43% over the past week. Year-to-date, Shenyang Xingqi's performance stands at -26.42%, contrasting sharply with the broader market's slight decline of 0.24%. Despite these recent challenges, the company has reported strong financial metrics, including a net profit growth of 41.48% and a robust operating cash flow of CNY 771.22 million. With a market capitalization of CNY 9,788 million, Shenyang Xingqi remains a significant player in the pharmaceuticals and biotechnology sector.